Colorectal Cancer: Focus on Capecitabine

Clinical Medicine Reviews in Oncology
doi 10.4137/cmro.s1599
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Portico

Related search

Metastatic Breast Cancer: Focus on Capecitabine

Clinical Medicine Reviews in Oncology
2010English

Role of Capecitabine in Treating Metastatic Colorectal Cancer in Chinese Patients

OncoTargets and Therapy
OncologyPharmacology
2014English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

The Rationale for Liquid Biopsy in Colorectal Cancer: A Focus on Circulating Tumor Cells

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2015English

The Clinical and Economic Benefits of Capecitabine and Tegafur With Uracil in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2006English

Reply: The Clinical and Economic Benefits of Capecitabine and Tegafur With Uracil in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2007English

Phase-Ii Study of Dose Attenuated Schedule of Irinotecan, Capecitabine, and Celecoxib in Advanced Colorectal Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2007English

A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy